Treating hypertension – a new approach

0
Hypertension is the leading cause of cardiovascular disease, affecting 1.13 billion people worldwide, including six million adult Australians. Research has indicated that a new pharmacological...

Re-thinking opioids

0
Pharmacists can minimise opioid harm by helping patients step down. While opioids play an important role in the management of acute pain, their widespread use...

Age of anxiety

0
Anxiety is the most common mental health condition in Australia, and research shows the pandemic has only exacerbated the issue. Are we doing enough to support those who experience it?

PSA’s projects make a bigger impact than ever before

0
The PSA released its 2025 Strategic Projects Impact Report last week, showcasing its leadership in advancing pharmacist practice.

Call for pharmacist access to the MBS for Chronic Disease Management

0
Pharmacists within general practice is a positive step forward, but the exclusion from MBS Team Care arrangements in CDM items makes no sense. After a...

Harnessing different abilities

0
Some might assume employing someone with a declared disability would only bring complications. But some community pharmacies around Australia are leading the way in...